Cytosorbents Corporation (CTSO)
USD 1.0
(1.18%)
USD 1.0
(1.18%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -28.5 Million USD | 13.12% |
| 2022 | -32.81 Million USD | -33.61% |
| 2021 | -24.55 Million USD | -213.37% |
| 2020 | -7.83 Million USD | 59.32% |
| 2019 | -19.26 Million USD | -11.94% |
| 2018 | -17.21 Million USD | -103.42% |
| 2017 | -8.46 Million USD | 29.13% |
| 2016 | -11.93 Million USD | -46.82% |
| 2015 | -8.13 Million USD | 12.76% |
| 2014 | -9.32 Million USD | -99.26% |
| 2013 | -4.67 Million USD | -27.69% |
| 2012 | -3.66 Million USD | 33.17% |
| 2011 | -5.48 Million USD | -88.45% |
| 2010 | -2.9 Million USD | -6.29% |
| 2009 | -2.73 Million USD | 9.32% |
| 2008 | -3.01 Million USD | 9.93% |
| 2007 | -3.35 Million USD | 56.32% |
| 2006 | -7.67 Million USD | -9489.48% |
| 2005 | -80 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -6.35 Million USD | -8.96% |
| 2024 Q2 | -4.14 Million USD | 34.83% |
| 2023 Q4 | -5.83 Million USD | 36.53% |
| 2023 Q2 | -6.15 Million USD | 8.98% |
| 2023 Q1 | -6.76 Million USD | -782.36% |
| 2023 Q3 | -9.19 Million USD | -49.4% |
| 2023 FY | -28.5 Million USD | 13.12% |
| 2022 Q3 | -12.15 Million USD | -11.72% |
| 2022 Q4 | -766.12 Thousand USD | 93.7% |
| 2022 Q2 | -10.87 Million USD | -21.44% |
| 2022 FY | -32.81 Million USD | -33.61% |
| 2022 Q1 | -8.95 Million USD | 3.75% |
| 2021 Q4 | -9.3 Million USD | -45.28% |
| 2021 FY | -24.55 Million USD | -213.37% |
| 2021 Q1 | -4.16 Million USD | -514.97% |
| 2021 Q2 | -4.67 Million USD | -12.23% |
| 2021 Q3 | -6.4 Million USD | -36.96% |
| 2020 Q1 | -3.45 Million USD | 12.57% |
| 2020 Q2 | -2.86 Million USD | 16.97% |
| 2020 Q4 | -677.72 Thousand USD | 19.32% |
| 2020 Q3 | -840 Thousand USD | 70.7% |
| 2020 FY | -7.83 Million USD | 59.32% |
| 2019 Q1 | -4.88 Million USD | 9.61% |
| 2019 FY | -19.26 Million USD | -11.94% |
| 2019 Q2 | -3.54 Million USD | 27.36% |
| 2019 Q3 | -6.88 Million USD | -94.09% |
| 2019 Q4 | -3.94 Million USD | 42.64% |
| 2018 Q1 | -2.98 Million USD | 5.24% |
| 2018 Q2 | -5.82 Million USD | -95.21% |
| 2018 FY | -17.21 Million USD | -103.42% |
| 2018 Q3 | -3 Million USD | 48.38% |
| 2018 Q4 | -5.4 Million USD | -79.82% |
| 2017 Q3 | -2.05 Million USD | -84.01% |
| 2017 FY | -8.46 Million USD | 29.13% |
| 2017 Q1 | -1.37 Million USD | 68.79% |
| 2017 Q2 | -1.11 Million USD | 18.99% |
| 2017 Q4 | -3.14 Million USD | -53.19% |
| 2016 Q2 | -3 Million USD | -63.66% |
| 2016 Q1 | -1.83 Million USD | 8.26% |
| 2016 FY | -11.93 Million USD | -46.82% |
| 2016 Q4 | -4.41 Million USD | -64.56% |
| 2016 Q3 | -2.68 Million USD | 10.73% |
| 2015 Q4 | -2 Million USD | 29.7% |
| 2015 FY | -8.13 Million USD | 12.76% |
| 2015 Q3 | -2.84 Million USD | -298.52% |
| 2015 Q2 | 1.43 Million USD | 130.41% |
| 2015 Q1 | -4.71 Million USD | 5.56% |
| 2014 Q3 | -1.49 Million USD | 19.17% |
| 2014 Q2 | -1.85 Million USD | -90.1% |
| 2014 Q1 | -975.08 Thousand USD | -45.74% |
| 2014 FY | -9.32 Million USD | -99.26% |
| 2014 Q4 | -4.99 Million USD | -233.34% |
| 2013 Q4 | -669.07 Thousand USD | 30.65% |
| 2013 Q1 | -1.62 Million USD | -202.99% |
| 2013 Q2 | -1.41 Million USD | 13.13% |
| 2013 Q3 | -964.78 Thousand USD | 31.82% |
| 2013 FY | -4.67 Million USD | -27.69% |
| 2012 FY | -3.66 Million USD | 33.17% |
| 2012 Q1 | -1.42 Million USD | -19.19% |
| 2012 Q3 | -651.98 Thousand USD | 37.75% |
| 2012 Q2 | -1.04 Million USD | 26.59% |
| 2012 Q4 | -537.62 Thousand USD | 17.54% |
| 2011 Q4 | -1.19 Million USD | 30.77% |
| 2011 Q1 | -1.21 Million USD | -155.65% |
| 2011 Q2 | -1.34 Million USD | -10.42% |
| 2011 Q3 | -1.72 Million USD | -28.91% |
| 2011 FY | -5.48 Million USD | -88.45% |
| 2010 Q2 | -676.27 Thousand USD | 30.21% |
| 2010 Q4 | -475.1 Thousand USD | 39.74% |
| 2010 Q3 | -788.43 Thousand USD | -16.58% |
| 2010 FY | -2.9 Million USD | -6.29% |
| 2010 Q1 | -969.05 Thousand USD | -241.74% |
| 2009 Q4 | -283.56 Thousand USD | 66.29% |
| 2009 Q2 | -851.94 Thousand USD | -12.08% |
| 2009 Q1 | -760.15 Thousand USD | -16.34% |
| 2009 FY | -2.73 Million USD | 9.32% |
| 2009 Q3 | -841.05 Thousand USD | 1.28% |
| 2008 Q2 | -855.63 Thousand USD | -32.44% |
| 2008 FY | -3.01 Million USD | 9.93% |
| 2008 Q1 | -646.05 Thousand USD | -7.79% |
| 2008 Q4 | -653.41 Thousand USD | 24.26% |
| 2008 Q3 | -862.75 Thousand USD | -0.83% |
| 2007 Q2 | -714.05 Thousand USD | 50.7% |
| 2007 FY | -3.35 Million USD | 56.32% |
| 2007 Q4 | -599.34 Thousand USD | -1.79% |
| 2007 Q3 | -588.82 Thousand USD | 17.54% |
| 2007 Q1 | -1.44 Million USD | -76.66% |
| 2006 Q4 | -819.96 Thousand USD | -26.99% |
| 2006 Q1 | -10.84 Thousand USD | -25.62% |
| 2006 Q3 | -645.7 Thousand USD | 87.56% |
| 2006 FY | -7.67 Million USD | -9489.48% |
| 2006 Q2 | -5.19 Million USD | -47761.08% |
| 2005 FY | -80 Thousand USD | 0.0% |
| 2005 Q4 | -8633.00 USD | 16.57% |
| 2005 Q3 | -10.34 Thousand USD | 48.27% |
| 2005 Q2 | -20 Thousand USD | -100.0% |
| 2005 Q1 | -10 Thousand USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 53.735% |
| BrainsWay Ltd. | -4.19 Million USD | -579.233% |
| Cerus Corporation | -37.48 Million USD | 23.958% |
| Envoy Medical, Inc. | -29.9 Million USD | 4.683% |
| electroCore, Inc. | -18.83 Million USD | -51.361% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -222.117% |
| IceCure Medical Ltd | -14.65 Million USD | -94.563% |
| Inogen, Inc. | -102.44 Million USD | 72.174% |
| OrthoPediatrics Corp. | -20.97 Million USD | -35.918% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 45.871% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -107.399% |
| MaxCyte, Inc. | -37.92 Million USD | 24.828% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -140.376% |
| Nexalin Technology, Inc. | -4.64 Million USD | -513.232% |
| Orthofix Medical Inc. | -151.39 Million USD | 81.17% |
| PAVmed Inc | -64.17 Million USD | 55.579% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 45.666% |
| RxSight, Inc. | -48.6 Million USD | 41.352% |
| Sight Sciences, Inc. | -55.54 Million USD | 48.679% |
| SI-BONE, Inc. | -43.33 Million USD | 34.218% |
| TELA Bio, Inc. | -46.66 Million USD | 38.909% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 42.441% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -109.876% |
| Acutus Medical, Inc. | -81.66 Million USD | 65.091% |
| Talis Biomedical Corporation | -62 Million USD | 54.026% |
| Spectral AI, Inc. | -20.85 Million USD | -36.7% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 53.094% |
| CVRx, Inc. | -41.19 Million USD | 30.806% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 4552.917% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -160.216% |
| Bioventus Inc. | -156.23 Million USD | 81.753% |
| Venus Concept Inc. | -37.25 Million USD | 23.47% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 51.713% |
| LivaNova PLC | 17.54 Million USD | 262.472% |
| 908 Devices Inc. | -36.39 Million USD | 21.681% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 84.726% |
| Nemaura Medical Inc. | -14.14 Million USD | -101.555% |
| NeuroPace, Inc. | -32.95 Million USD | 13.499% |
| LENSAR, Inc. | -14.38 Million USD | -98.202% |
| Apyx Medical Corporation | -18.71 Million USD | -52.34% |
| Cutera, Inc. | -162.83 Million USD | 82.493% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -163.226% |
| BioSig Technologies, Inc. | -29.04 Million USD | 1.837% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 65.515% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | -29.057% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 142.083% |
| Axonics, Inc. | -6.08 Million USD | -368.255% |
| Outset Medical, Inc. | -172.79 Million USD | 83.502% |
| IRIDEX Corporation | -9.57 Million USD | -197.883% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 73.08% |
| IRadimed Corporation | 17.19 Million USD | 265.81% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -245.796% |
| INVO Bioscience, Inc. | -8.03 Million USD | -254.807% |
| Telesis Bio, Inc. | -47.72 Million USD | 40.266% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 378.311% |
| Varex Imaging Corporation | -47.7 Million USD | 40.236% |
| Quipt Home Medical Corp. | -2.78 Million USD | -923.972% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -152.591% |
| Pulmonx Corporation | -60.84 Million USD | 53.146% |
| Dynatronics Corporation | -2.69 Million USD | -956.722% |
| Modular Medical, Inc. | -17.47 Million USD | -63.179% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -150.35% |
| Semler Scientific, Inc. | 20.58 Million USD | 238.5% |
| InMode Ltd. | 197.91 Million USD | 114.404% |
| Bruker Corporation | 427.2 Million USD | 106.673% |
| DexCom, Inc. | 541.5 Million USD | 105.265% |
| Align Technology, Inc. | 445.05 Million USD | 106.405% |
| Viveve Medical, Inc. | -22.02 Million USD | -29.42% |
| ZimVie Inc. | -393.28 Million USD | 92.751% |
| Movano Inc. | -29.28 Million USD | 2.649% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -134.667% |
| Nexalin Technology, Inc. | -4.64 Million USD | -513.232% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 4552.917% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 87.194% |
| Profound Medical Corp. | -28.56 Million USD | 0.216% |
| Insulet Corporation | 206.3 Million USD | 113.818% |
| enVVeno Medical Corporation | -23.51 Million USD | -21.226% |
| Surmodics, Inc. | -11.54 Million USD | -146.988% |
| iCAD, Inc. | -4.84 Million USD | -488.145% |
| Nuwellis, Inc. | -20.2 Million USD | -41.063% |
| Biotricity, Inc. | -14.09 Million USD | -102.262% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 76.9% |
| Aethlon Medical, Inc. | -12.2 Million USD | -133.511% |
| InspireMD, Inc. | -19.91 Million USD | -43.138% |
| PAVmed Inc. | -64.17 Million USD | 55.579% |
| BIOLASE, Inc. | -20.63 Million USD | -38.171% |
| Beyond Air, Inc. | -60.24 Million USD | 52.679% |
| FONAR Corporation | 10.56 Million USD | 369.767% |
| AxoGen, Inc. | -21.71 Million USD | -31.274% |
| Vivani Medical, Inc. | -25.65 Million USD | -11.131% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 199.973% |
| Inari Medical, Inc. | -1.63 Million USD | -1642.506% |
| UFP Technologies, Inc. | 44.92 Million USD | 163.457% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -455.447% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -331.59% |
| Tenon Medical, Inc. | -15.58 Million USD | -82.963% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -84.801% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 19.318% |
| AdaptHealth Corp. | -678.89 Million USD | 95.801% |
| Sintx Technologies, Inc. | -8.25 Million USD | -245.168% |
| NanoVibronix, Inc. | -3.71 Million USD | -668.186% |
| Quanterix Corporation | -32.33 Million USD | 11.835% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -152.591% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 5977.813% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 90.706% |
| TransMedics Group, Inc. | -25.02 Million USD | -13.902% |
| ReWalk Robotics Ltd. | -22.13 Million USD | -28.8% |
| NeuroMetrix, Inc. | -6.52 Million USD | -336.595% |
| Hyperfine, Inc. | -44.23 Million USD | 35.559% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 63.686% |
| Biomerica, Inc. | -5.97 Million USD | -376.872% |
| Bone Biologics Corporation | -8.94 Million USD | -218.564% |
| AVITA Medical, Inc. | -39.16 Million USD | 27.218% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -186.395% |
| Silk Road Medical, Inc | -55.74 Million USD | 48.859% |